[{"indications": "Indications\u00a0mild to moderate dementia in Alzheimer\u2019s disease", "name": "GALANTAMINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.11 Drugs for dementia", "GALANTAMINE"], "cautions": "Cautions\u00a0cardiac disease (including sick sinus syndrome or other supraventricular\r\nconduction abnormalities, unstable angina, congestive heart failure); electrolyte disturbances; susceptibility\r\nto peptic ulcers; asthma, chronic obstructive pulmonary disease, pulmonary infection; avoid in urinary\r\nretention, gastro-intestinal obstruction, and while recovering\r\nfrom bladder or gastro-intestinal surgery; history of seizures; interactions: Appendix 1 (parasympathomimetics)", "side-effects": "Side-effects\u00a0vomiting, nausea, abdominal pain, diarrhoea, dyspepsia,\r\nanorexia, weight loss, bradycardia, hypertension, syncope, hallucination,\r\ndepression, dizziness, tremor, headache, drowsiness, malaise, muscle\r\nspasm, sweating; less commonly taste disturbance,\r\npalpitation, arrhythmias, first-degree AV block, hypotension, flushing,\r\nparaesthesia, dehydration, muscular weakness, blurred vision, tinnitus; rarely hepatitis, exacerbation of Parkinson\u2019s disease, seizures", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/89495.htm", "doses": ["Initially 4\u00a0mg twice daily for 4 weeks increased to 8\u00a0mg\r\ntwice daily for 4 weeks; maintenance 8\u201312\u00a0mg twice daily"]}, {"indications": "Indications\u00a0mild to moderate dementia in Alzheimer\u2019s disease", "name": "GALANTAMINE Modified release", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.11 Drugs for dementia", "GALANTAMINE", "Modified release"], "cautions": "Cautions\u00a0cardiac disease (including sick sinus syndrome or other supraventricular\r\nconduction abnormalities, unstable angina, congestive heart failure); electrolyte disturbances; susceptibility\r\nto peptic ulcers; asthma, chronic obstructive pulmonary disease, pulmonary infection; avoid in urinary\r\nretention, gastro-intestinal obstruction, and while recovering\r\nfrom bladder or gastro-intestinal surgery; history of seizures; interactions: Appendix 1 (parasympathomimetics)", "side-effects": "Side-effects\u00a0vomiting, nausea, abdominal pain, diarrhoea, dyspepsia,\r\nanorexia, weight loss, bradycardia, hypertension, syncope, hallucination,\r\ndepression, dizziness, tremor, headache, drowsiness, malaise, muscle\r\nspasm, sweating; less commonly taste disturbance,\r\npalpitation, arrhythmias, first-degree AV block, hypotension, flushing,\r\nparaesthesia, dehydration, muscular weakness, blurred vision, tinnitus; rarely hepatitis, exacerbation of Parkinson\u2019s disease, seizures", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129261.htm", "doses": ["Initially 4\u00a0mg twice daily for 4 weeks increased to 8\u00a0mg\r\ntwice daily for 4 weeks; maintenance 8\u201312\u00a0mg twice daily", "Name[Reminyl\u00ae XL (Shire) ] Capsules, m/r, galantamine (as hydrobromide)\r\n8\u00a0mg (white), net price 28-cap pack = \u00a351.88; 16\u00a0mg (pink), 28-cap\r\npack = \u00a364.90; 24\u00a0mg (beige), 28-cap pack = \u00a379.80. \r\n    Label:\r\n    3, 21, 25Dose\u00a0initially 8\u00a0mg once daily for 4 weeks increased to 16\u00a0mg\r\nonce daily for 4 weeks; maintenance 16\u201324\u00a0mg daily"]}]